2021年7月3日全球新冠肺炎疫情及疫苗接种简报:日新增43.1万,德尔塔变异株已在至少98个国家和地区出现 且在继续变异和进化

2021-07-03 MedSci整理 MedSci整理

截至北京时间2021年7月3日8时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过18383万例,新增431,171例,达到183,832,389

截至北京时间2021年7月3日8时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过18383万例,新增431,171例,达到183,832,389例。累计死亡病例397.9万例,达到3,979,440例。新增死亡为8,249例。康复为168,265,389例,重症和危重症病人达到78,067例,降至8万例以内;全球新冠确诊病例超过100万例的国家达28个,97个国家病例超10万例。昨日报道:2021年7月2日全球新冠肺炎疫情及疫苗接种简报:日新增41.7万,美国在全球疫情爆发前就已开始疫苗开发

美国单日新增确诊超1.9万例 1000个县新冠疫苗接种率不足30%

根据Worldometer实时统计数据,截至北京时间7月3日6时30分左右,美国累计确诊新冠肺炎病例34576367例,累计死亡病例620947例。与前一日6时30分数据相比,美国新增确诊病例19168例,新增死亡病例330例。

据美国媒体报道,美国疾控中心当地时间1日表示,美国现在有约1000个县的新冠疫苗接种率仍不足30%,让社区陷入了变异病毒传播的风险之中。

巴西日增确诊病例超6.5万例 疫苗接种计划推进使死亡病例出现一定程度下降

截至当地时间7月1日,据巴西卫生部发布的数据,该国新冠肺炎单日新增确诊病例65165例,累计确诊病例达18687469例;单日新增死亡病例1857例,累计死亡521952例。

6月30日,巴西权威医疗科研机构奥斯瓦尔多·克鲁兹基金会发布的调查报告显示,随着该国新冠疫苗接种计划的推进,相关死亡病例和重症床位的占用率都出现了一定程度的下降。

报告指出,目前,该国对老年人、医务工作者等新冠肺炎高风险感染群体的接种覆盖范围高于其他群体,这可能是上述死亡病例和重症床位占用率有所下降的主要原因。统计显示,在6月20日至26日,巴西全国7日内新增死亡病例动态平均数为1700例,较前一周下降了2.5%。同时,研究人员表示,在6月28日当天,巴西东北部和中西部地区的公立医院成年人新冠肺炎重症床位占用率出现了明显下降。

印度日增确诊病例超4.6万例 多名专家警告可能会迎来第三波疫情

据印度卫生部2日公布的最新数据,印度新冠肺炎确诊病例升至30458251例。在过去24小时内,印度新增确诊病例46617例;新增死亡病例853例,累计死亡病例首次超40万,达400312例。

由于印度各邦近来采取了较为严格的防疫封锁措施,该国单日新增确诊病例数已从5月高峰时的超过40万例降至目前的5万例以下。不过,变异新冠病毒传播、疫苗接种率较低、解封带来人员大量流动等因素使得印度未来疫情形势仍不容乐观。多名专家警告,印度可能会迎来第三波疫情。

俄罗斯日增确诊病例超2.3万例 莫斯科市启动新冠疫苗补充接种工作

据俄罗斯新冠病毒防疫官网2日公布的最新数据,俄罗斯新增新冠肺炎确诊病例23218例,累计确诊5561360例,新增新冠肺炎死亡病例679例,累计死亡136565例。

疫情严重的莫斯科市已于7月1日启动新冠疫苗补充接种工作。莫斯科市市长索比亚宁表示,自7月1日起,市民可在市内的8座“健康莫斯科”卫生站补充接种疫苗。自7月5日起,莫斯科12所城市医院将开始接受补充接种的预约。索比亚宁还表示,在感染性更强的Delta毒株传播的背景下,补充接种极为重要,医生建议每半年接种一次新冠疫苗

世卫组织:德尔塔变异株已在至少98个国家和地区出现 且在继续变异和进化

当地时间7月2日,世卫组织举行新冠肺炎例行发布会,世卫组织总干事谭德塞表示,德尔塔变异株正在很多国家成为主要流行毒株。目前,疫情正处于非常危险的阶段,还没有国家能脱离困境。在新冠疫苗覆盖率较低的国家,当地医院正逐渐人满为患。

德尔塔变异株已在至少98个国家和地区出现。该变异株较为危险,而且在继续变异和进化,因此需要持续不断评估和调整公共卫生措施。

意大利已有16个地区发现德尔塔变异株

当地时间7月2日,意大利高等卫生研究院院长布鲁萨费罗在每周疫情发布会上表示,截至6月22日,意大利21个大区和自治省中有16个地区发现了德尔塔变异毒株感染病例。

该国新增确诊病例中被德尔塔变异毒株感染的病例占新增确诊病例总数的22.7%,最高的地区占比达70.6%。

法国卫生部长:法国今夏有疫情反弹的风险

当地时间7月2日,法国卫生部长韦朗在到访位于巴黎西郊上塞纳省的一个疫苗接种中心时表示,到目前为止法国新增新冠肺炎病例中有三分之一感染的是德尔塔变异毒株,该变异株的加速传播已构成真正的威胁,法国在今年夏季就存在疫情反弹的风险。

为此,韦朗呼吁民众尽快通过接种新冠疫苗来加大防控力度。但他同时强调,法国政府不会强制全民接种,目前只有医护人员在强制接种疫苗的考虑之列。

2021年7月1日:31省份已累计报告接种新冠病毒疫苗12亿6414.9万剂次,新增1947.4万剂次

据国家卫健委网站消息,截至2021年7月1日,31个省(自治区、直辖市)和新疆生产建设兵团累计报告接种新冠病毒疫苗126414.9万剂次。

上一日累计报告接种新冠病毒疫苗124467.5万剂次,新增1947.4万剂

全球新冠疫苗接种概况

Country
Cumulative COVID-19 vaccinations doses
World 3.13 billion
Asia 1.94 billion
Upper middle income 1.68 billion
China 1.26 billion
High income 992.02 million
Europe 510.62 million
Lower middle income 452.82 million
North America 435.74 million
European Union 367.21 million
India 334.74 million
United States 328.15 million
South America 185.51 million
Brazil 102.78 million
United Kingdom Jun 30, 2021 77.91 million
Germany Jun 30, 2021 74.87 million
England Jun 30, 2021 65.39 million
France Jun 30, 2021 54.48 million
Italy 52.11 million
Africa 51.30 million
Turkey 51.21 million
Japan 46.25 million
Mexico Jun 30, 2021 45.90 million
Indonesia 44.16 million
Spain Jun 30, 2021 42.03 million
Russia 40.88 million
Canada 37.42 million
Poland 29.54 million
Chile Jun 29, 2021 22.74 million
Argentina 20.91 million
South Korea 19.37 million
Morocco 19.17 million
Colombia Jun 30, 2021 18.28 million
Saudi Arabia 18.02 million
Pakistan 16.36 million
Netherlands 15.51 million
United Arab Emirates Jun 30, 2021 15.36 million
Belgium Jun 30, 2021 10.91 million
Israel 10.79 million
Philippines 10.70 million
Bangladesh Jun 30, 2021 10.10 million

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1258046, encodeId=9d39125804672, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jul 04 23:52:34 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342853, encodeId=2bd61342853e0, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sun Jul 04 23:52:34 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995775, encodeId=0684995e7556, content=有没有详细的对肿瘤患者接种疫苗的利弊权衡的介绍, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109f5527915, createdName=懿妈, createdTime=Sat Jul 03 16:59:57 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029688, encodeId=c07f10296880c, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Jul 03 11:52:34 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995638, encodeId=529a995638fd, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sat Jul 03 09:53:53 CST 2021, time=2021-07-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1258046, encodeId=9d39125804672, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jul 04 23:52:34 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342853, encodeId=2bd61342853e0, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sun Jul 04 23:52:34 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995775, encodeId=0684995e7556, content=有没有详细的对肿瘤患者接种疫苗的利弊权衡的介绍, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109f5527915, createdName=懿妈, createdTime=Sat Jul 03 16:59:57 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029688, encodeId=c07f10296880c, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Jul 03 11:52:34 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995638, encodeId=529a995638fd, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sat Jul 03 09:53:53 CST 2021, time=2021-07-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1258046, encodeId=9d39125804672, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jul 04 23:52:34 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342853, encodeId=2bd61342853e0, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sun Jul 04 23:52:34 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995775, encodeId=0684995e7556, content=有没有详细的对肿瘤患者接种疫苗的利弊权衡的介绍, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109f5527915, createdName=懿妈, createdTime=Sat Jul 03 16:59:57 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029688, encodeId=c07f10296880c, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Jul 03 11:52:34 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995638, encodeId=529a995638fd, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sat Jul 03 09:53:53 CST 2021, time=2021-07-03, status=1, ipAttribution=)]
    2021-07-03 懿妈

    有没有详细的对肿瘤患者接种疫苗的利弊权衡的介绍

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1258046, encodeId=9d39125804672, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jul 04 23:52:34 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342853, encodeId=2bd61342853e0, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sun Jul 04 23:52:34 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995775, encodeId=0684995e7556, content=有没有详细的对肿瘤患者接种疫苗的利弊权衡的介绍, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109f5527915, createdName=懿妈, createdTime=Sat Jul 03 16:59:57 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029688, encodeId=c07f10296880c, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Jul 03 11:52:34 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995638, encodeId=529a995638fd, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sat Jul 03 09:53:53 CST 2021, time=2021-07-03, status=1, ipAttribution=)]
    2021-07-03 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1258046, encodeId=9d39125804672, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jul 04 23:52:34 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342853, encodeId=2bd61342853e0, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sun Jul 04 23:52:34 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995775, encodeId=0684995e7556, content=有没有详细的对肿瘤患者接种疫苗的利弊权衡的介绍, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109f5527915, createdName=懿妈, createdTime=Sat Jul 03 16:59:57 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029688, encodeId=c07f10296880c, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Jul 03 11:52:34 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995638, encodeId=529a995638fd, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sat Jul 03 09:53:53 CST 2021, time=2021-07-03, status=1, ipAttribution=)]
    2021-07-03 weigq

    👍👍👍

    0

相关资讯

担忧免疫力下降,英国计划9月开始接种新冠疫苗加强针

英国政府表示,正在准备从9月开始提供新冠疫苗的加强针,以备需要在最初接种带来的免疫力减弱时增强保护效力,以及提高对新冠病毒变种的防护力。

“新冠疫苗获取机制”呼吁平等承认世卫组织批准的所有疫苗

联合国新闻网消息,“新冠疫苗获取机制”(COVAX)建立在公平获得新冠疫苗的原则上,以保护全球各地人民的健康。这意味着保护他们的生命和生计,包括进行旅行和贸易的能力。随着旅行和

Nature:80岁以上老人,需接种两针新冠疫苗才能达到更佳防护效果

2021年6月30日,英国剑桥大学等机构的研究人员在国际顶尖学术期刊 Nature 发表了题为:Age-related immune response heterogeneity to SARS-Co

Cancer Cell:94% 的癌症患者对 COVID-19 疫苗反应良好

当注射两剂mrna疫苗后,大多数 (94%) 癌症患者实现了血清转换,但是血液系统恶性肿瘤患者的血清转化率和抗体滴度显着低于实体瘤者。

全球鼻腔内COVID-19疫苗1期研究结果可喜

纽约当地时间6月30日,美国生物学公司 Codagenix, Inc宣布,在《美国国家科学院院刊》(PNAS)上发表的临床前数据支持公司的鼻内减毒活疫苗 COVI-VAC 的潜在安全性和有效性。

2021年7月2日全球新冠肺炎疫情及疫苗接种简报:日新增41.7万,美国在全球疫情爆发前就已开始疫苗开发

截至北京时间2021年7月2日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过18338万例,新增417,219例,达到183,382,754